| 摘要 |
<p>Described is the use of a xenon/carbon monoxide mixture for protecting cells, cell complexes, tissues and/or organs, e.g., from diseased cell turnover, apoptosis, aberrant programming of (unintentional) cell division, necrosis and/or cell death. Preferred clinical indications requiring cell protection or stabilisation of cell cycle/turnover are (a) ischemia reperfusion (e.g., in case of myocardial infarction, stroke and heart surgery), (b) tumour/cancer related disease states and (c) neurodegenerative diseases like all kinds of dementia (e.g., Alzheimer's disease), Parkinson disease and organic psychiatric disease.)</p> |
